POLYPHARMACY EXPERIENCE IN GERIATRIC HEMATOLOGY

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Eskisehir Medical Journal
Volume:5 Issue:3
POLYPHARMACY EXPERIENCE IN GERIATRIC HEMATOLOGY

POLYPHARMACY EXPERIENCE IN GERIATRIC HEMATOLOGY

Authors : Abdulkadir Karısmaz, Istemi Serın, Ceyda Aslan, Damla Kızıl, Rafet Eren, Elif Suyani

Pages : 86-91

View : 36 | Download : 34

Publication Date : 2024-11-30

Article Type : Research Paper

Abstract :Background: Polypharmacy in hematological malignancies is also a research area with very little literature data. The development of personalized treatment approaches in this patient group is con-siderable for future needs. In our study, the aim was to investigate the effects of polypharmacy on treatment response, and survival in elderly patients with different hematological malignancies. Method: The data of 91 patients, who were ≥ 60 years old, with the diagnosis of a hematological malignancy was analyzed retrospectively. Results: The probability of overall survival at the end of the follow-up was 36% in patients receiv-ing ≤ 6 drugs, and 46% in patients receiving > 6 drugs (p=0.271). In subgroup analysis regarding the diagnosis of the patients, there was no difference between subgroups. Conclusion: The polypharmacy is indispensable in a number of old patients with comorbidites, and this situation would not hinder the physicians from treating those patients with the diagnosis of he-matological maligancies, at least the indolent types.
Keywords : Polifarmasi, tedavi, yanıt, sağkalım, hematoloji

ORIGINAL ARTICLE URL

VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.